MKI67 and neoplasm: Importantly, other clinical features such as ER and PR status, age, and tumor grade, all extracted from the clinical data, as well as Ki67 expression derived from CyCIF analysis, did not associate with recurrence, and the clinical stage was only associated in the adjusted analyses (Table 8).